[
  {
    "ts": "2026-01-07T00:04:00+00:00",
    "headline": "Should You Buy Stocks If a Recession Is Coming in 2026? Here's What History Shows.",
    "summary": "The past reveals both good and bad news for investors.",
    "url": "https://www.fool.com/investing/2026/01/06/should-you-buy-stocks-if-a-recession-is-coming-in/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f7989f7d-a9d2-33b9-b80e-19d509e9886a",
      "content": {
        "id": "f7989f7d-a9d2-33b9-b80e-19d509e9886a",
        "contentType": "STORY",
        "title": "Should You Buy Stocks If a Recession Is Coming in 2026? Here's What History Shows.",
        "description": "",
        "summary": "The past reveals both good and bad news for investors.",
        "pubDate": "2026-01-07T00:04:00Z",
        "displayTime": "2026-01-07T00:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/81c2eeb3d1be504f0d79de06a63ec852",
          "originalWidth": 1400,
          "originalHeight": 921,
          "caption": "Recession ahead road sign with dark skies in the background.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3whQkTRmAHZojAHcb9dvlQ--~B/aD05MjE7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/81c2eeb3d1be504f0d79de06a63ec852.cf.webp",
              "width": 1400,
              "height": 921,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yeW2cK9kIHCdMAN6nN66iw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/81c2eeb3d1be504f0d79de06a63ec852.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/06/should-you-buy-stocks-if-a-recession-is-coming-in/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-stocks-recession-coming-2026-000400556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T02:44:00+00:00",
    "headline": "Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies",
    "summary": "The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (\"Kelun-Biotech\" or the \"Company\", 6990.HK) has been invited to attend the conference and Dr. Michael Ge, President and CEO of Kelun-Biotech, will share the company's latest business progresses as well as its innovation capabilities and strategies.",
    "url": "https://finance.yahoo.com/news/kelun-biotech-attend-44th-j-024400549.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "7b4e10b8-1133-3967-8737-8f016dc41d77",
      "content": {
        "id": "7b4e10b8-1133-3967-8737-8f016dc41d77",
        "contentType": "STORY",
        "title": "Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies",
        "description": "",
        "summary": "The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (\"Kelun-Biotech\" or the \"Company\", 6990.HK) has been invited to attend the conference and Dr. Michael Ge, President and CEO of Kelun-Biotech, will share the company's latest business progresses as well as its innovation capabilities and strategies.",
        "pubDate": "2026-01-07T02:44:00Z",
        "displayTime": "2026-01-07T02:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/5455aad5e4ea0b08ff580f6c7e429747",
          "originalWidth": 400,
          "originalHeight": 116,
          "caption": "(PRNewsfoto/四川科倫博泰生物醫藥股份有限公司)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VTgKsjcleJYGpmSV4OUUrg--~B/aD0xMTY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5455aad5e4ea0b08ff580f6c7e429747.cf.webp",
              "width": 400,
              "height": 116,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fdhgu2QEHADwKfeMLn1W_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5455aad5e4ea0b08ff580f6c7e429747.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kelun-biotech-attend-44th-j-024400549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kelun-biotech-attend-44th-j-024400549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "6990.HK"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T05:09:25+00:00",
    "headline": "Is JPMorgan Chase (JPM) Fairly Priced After Big Gains And Capital Rule Headlines",
    "summary": "If you are wondering whether JPMorgan Chase is still fairly priced after a strong run, this article walks through what the current share price could imply about value. With the stock at US$334.61, recent returns of 3.5% over 7 days, 6.2% over 30 days, 2.8% year to date, 40.4% over 1 year, 159.2% over 3 years and 171.0% over 5 years put the current price in clear focus for investors thinking about upside and risk. Recent headlines around large US banks have centered on capital requirements...",
    "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-fairly-priced-050925713.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b9555f06-6ac9-351a-83da-9e26c7a371ca",
      "content": {
        "id": "b9555f06-6ac9-351a-83da-9e26c7a371ca",
        "contentType": "STORY",
        "title": "Is JPMorgan Chase (JPM) Fairly Priced After Big Gains And Capital Rule Headlines",
        "description": "",
        "summary": "If you are wondering whether JPMorgan Chase is still fairly priced after a strong run, this article walks through what the current share price could imply about value. With the stock at US$334.61, recent returns of 3.5% over 7 days, 6.2% over 30 days, 2.8% year to date, 40.4% over 1 year, 159.2% over 3 years and 171.0% over 5 years put the current price in clear focus for investors thinking about upside and risk. Recent headlines around large US banks have centered on capital requirements...",
        "pubDate": "2026-01-07T05:09:25Z",
        "displayTime": "2026-01-07T05:09:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/buiFSDj_0ot5Q6v9J14wWA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jnehXQ3eKjDwH262Ddswdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-fairly-priced-050925713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-jpm-fairly-priced-050925713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T07:00:00+00:00",
    "headline": "Bond Market Signals Go-Ahead For Bank Stocks with JP Morgan Earnings On Deck",
    "summary": "A steeper yield curve and strong deal activity are lifting bank stocks ahead of JPMorgan’s earnings, with analysts expecting financials to drive a fifth of S&P 500 profits.",
    "url": "https://www.barrons.com/articles/jpmorgan-earnings-bank-stocks-bond-market-312c5a31?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "a82368d7-e172-3def-a0e8-9ccdbfca32d5",
      "content": {
        "id": "a82368d7-e172-3def-a0e8-9ccdbfca32d5",
        "contentType": "STORY",
        "title": "Bond Market Signals Go-Ahead For Bank Stocks with JP Morgan Earnings On Deck",
        "description": "",
        "summary": "A steeper yield curve and strong deal activity are lifting bank stocks ahead of JPMorgan’s earnings, with analysts expecting financials to drive a fifth of S&P 500 profits.",
        "pubDate": "2026-01-07T07:00:00Z",
        "displayTime": "2026-01-07T07:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a82368d7-e172-3def-a0e8-9ccdbfca32d5/bond-market-signals-go-ahead.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/861250656c7ea70399003ccf1778bc30",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tnh.cbFMLrKjGfcLuP4JSw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/861250656c7ea70399003ccf1778bc30.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/guL124rhmhacvNdl7SR3sw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/861250656c7ea70399003ccf1778bc30.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/jpmorgan-earnings-bank-stocks-bond-market-312c5a31?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T10:03:00+00:00",
    "headline": "JPMorganChase Survey: U.S. Business Leaders Signal Optimism and Growth Plans for 2026 Despite Economic Uncertainty",
    "summary": "NEW YORK, January 07, 2026--At the start of the year, strong optimism among U.S. business leaders is setting the stage for an active 2026, according to JPMorganChase’s annual Business Leaders Outlook survey of small and midsize companies. Following a year of persistent economic and geopolitical headwinds, business leaders are charting a path forward by pursuing growth opportunities, embracing emerging technologies and, in some cases, forging new strategic partnerships.",
    "url": "https://finance.yahoo.com/news/jpmorganchase-survey-u-business-leaders-100300167.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e6903471-4c0a-36ea-b381-a6bce6c9f5d4",
      "content": {
        "id": "e6903471-4c0a-36ea-b381-a6bce6c9f5d4",
        "contentType": "STORY",
        "title": "JPMorganChase Survey: U.S. Business Leaders Signal Optimism and Growth Plans for 2026 Despite Economic Uncertainty",
        "description": "",
        "summary": "NEW YORK, January 07, 2026--At the start of the year, strong optimism among U.S. business leaders is setting the stage for an active 2026, according to JPMorganChase’s annual Business Leaders Outlook survey of small and midsize companies. Following a year of persistent economic and geopolitical headwinds, business leaders are charting a path forward by pursuing growth opportunities, embracing emerging technologies and, in some cases, forging new strategic partnerships.",
        "pubDate": "2026-01-07T10:03:00Z",
        "displayTime": "2026-01-07T10:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/447a4a980a6cb829f6359f9520fe4017",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ie8VRCLF_TJagmr1ZNPRXw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/447a4a980a6cb829f6359f9520fe4017.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r3rxN9YrrUKRq2J9h54x7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/447a4a980a6cb829f6359f9520fe4017.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorganchase-survey-u-business-leaders-100300167.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorganchase-survey-u-business-leaders-100300167.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T10:00:28+00:00",
    "headline": "America's midsize businesses express 'cautious optimism' for 2026 after exuberant 2025: JPMorgan survey",
    "summary": "JPMorgan's latest survey of America's middle-market businesses shows some \"cautious optimism\" as 2026 gets underway after enthusiasm ran high a year ago.",
    "url": "https://finance.yahoo.com/news/americas-midsize-businesses-express-cautious-optimism-for-2026-after-exuberant-2025-jpmorgan-survey-100028626.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "096b0c99-1332-4a0f-9e70-4c63af5af2c7",
      "content": {
        "id": "096b0c99-1332-4a0f-9e70-4c63af5af2c7",
        "contentType": "STORY",
        "title": "America's midsize businesses express 'cautious optimism' for 2026 after exuberant 2025: JPMorgan survey",
        "description": "",
        "summary": "JPMorgan's latest survey of America's middle-market businesses shows some \"cautious optimism\" as 2026 gets underway after enthusiasm ran high a year ago.",
        "pubDate": "2026-01-07T10:00:28Z",
        "displayTime": "2026-01-07T10:00:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/bca5bd00-eb43-11f0-bff6-8b319499371d",
          "originalWidth": 7782,
          "originalHeight": 5188,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bu5MuGf8_bSWp7e062Qxlg--~B/aD01MTg4O3c9Nzc4MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/bca5bd00-eb43-11f0-bff6-8b319499371d.cf.webp",
              "width": 7782,
              "height": 5188,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fIm8Qu4pEoGxC_9zi57RiA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/bca5bd00-eb43-11f0-bff6-8b319499371d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/americas-midsize-businesses-express-cautious-optimism-for-2026-after-exuberant-2025-jpmorgan-survey-100028626.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/americas-midsize-businesses-express-cautious-optimism-for-2026-after-exuberant-2025-jpmorgan-survey-100028626.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:00:00+00:00",
    "headline": "Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference",
    "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, ...",
    "url": "https://finance.yahoo.com/news/amphastar-pharmaceuticals-present-j-p-110000234.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "da7e8bb5-1418-3763-82b9-f5ea43036e3f",
      "content": {
        "id": "da7e8bb5-1418-3763-82b9-f5ea43036e3f",
        "contentType": "STORY",
        "title": "Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference",
        "description": "",
        "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, ...",
        "pubDate": "2026-01-07T11:00:00Z",
        "displayTime": "2026-01-07T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/3e21340f78b8314f2f19950ba064a27b",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "<![CDATA[RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that ...]]>",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FXccynnpZxt.J_uH0syAIA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/3e21340f78b8314f2f19950ba064a27b.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ifYpUeoTorqkVHlului7rA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/3e21340f78b8314f2f19950ba064a27b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amphastar-pharmaceuticals-present-j-p-110000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amphastar-pharmaceuticals-present-j-p-110000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMPH"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T08:23:00+00:00",
    "headline": "How JPMorgan CEO Jamie Dimon notched $770 million in gains for his work in 2025",
    "summary": "Dimon has accumulated a lot of equity through his compensation plan, personal purchases, and via a 2021 special award.",
    "url": "https://finance.yahoo.com/news/jpmorgan-ceo-jamie-dimon-notched-082300670.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "d43b650f-14d7-3465-b63d-3f2ce96b68ef",
      "content": {
        "id": "d43b650f-14d7-3465-b63d-3f2ce96b68ef",
        "contentType": "STORY",
        "title": "How JPMorgan CEO Jamie Dimon notched $770 million in gains for his work in 2025",
        "description": "",
        "summary": "Dimon has accumulated a lot of equity through his compensation plan, personal purchases, and via a 2021 special award.",
        "pubDate": "2026-01-07T08:23:00Z",
        "displayTime": "2026-01-07T08:23:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/a5c880398c244dbb2e57173f8aed7e02",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "Jamie Dimon, chief executive officer of JPMorgan Chase & Co., speaks during the America Business Forum in Miami, Florida, US, on Thursday, Nov. 6, 2025.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CFWuivS.XfZxMXWVVbJP3A--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/a5c880398c244dbb2e57173f8aed7e02.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LZPwBA7Kvczk1vDqbha56Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/a5c880398c244dbb2e57173f8aed7e02.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-ceo-jamie-dimon-notched-082300670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-ceo-jamie-dimon-notched-082300670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:53+00:00",
    "headline": "The biggest market risk in 2026 is the one no one talks about",
    "summary": "Deal activity is heating up amid lower interest rates from the Fed and a sense from sellers that valuations are about as full as one could expect. Yahoo Finance executive editor Brian Sozzi sits down on the Opening Bid Unfiltered podcast with Apollo Global Management co-head of equity David Sambur. After being held by Liberation Day market related volatility, the environment for deal-making has picked up. 2025 was poised to become the second highest in deal activity, up 36% in value to an estimated $4.8 trillion according to Bain & Company. Megadeals greater than $5 billion represented more than 75% of incremental deal value. Meanwhile, exit activity for private equity companies accelerated meaningfully in the third quarter of last year. Private equity firms announced exits totaling $470 billion in 2025 per the latest data from EY, marking a 40% increase by value compared with the same period last year. Sambur shares his outlook for M&A and exits in 2026, the drivers of that potential activity and what he has learned from making big deals over the course of his career.Disclosure: Yahoo is a portfolio company of funds managed by affiliates of Apollo Global Management.",
    "url": "https://finance.yahoo.com/video/biggest-market-risk-2026-one-120053115.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "f291edb9-dd37-3364-b047-36dab913c0ac",
      "content": {
        "id": "f291edb9-dd37-3364-b047-36dab913c0ac",
        "contentType": "VIDEO",
        "title": "The biggest market risk in 2026 is the one no one talks about",
        "description": "<p>Deal activity is heating up amid lower interest rates from the Fed and a sense from sellers that valuations are about as full as one could expect. <br>Yahoo Finance executive editor <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/brian-sozzi/\">Brian Sozzi</a> sits down on the <a data-i13n=\"cpos:2;pos:1\" href=\"https://www.youtube.com/playlist?list=PLx28zU8ctIRrPPoWZxI2uK-uEGDIx0DDD\">Opening Bid Unfiltered</a> podcast with Apollo Global Management co-head of equity David Sambur. After being held by Liberation Day market related volatility, the environment for deal-making has picked up. 2025 was poised to become the second highest in deal activity, up 36% in value to an estimated $4.8 trillion according to Bain & Company. Megadeals greater than $5 billion represented more than 75% of incremental deal value. Meanwhile, exit activity for private equity companies accelerated meaningfully in the third quarter of last year. Private equity firms announced exits totaling $470 billion in 2025 per the latest data from EY, marking a 40% increase by value compared with the same period last year. Sambur shares his outlook for M&A and exits in 2026, the drivers of that potential activity and what he has learned from making big deals over the course of his career.<br><strong>Disclosure: Yahoo is a portfolio company of funds managed by affiliates of Apollo Global Management.</strong></p>",
        "summary": "Deal activity is heating up amid lower interest rates from the Fed and a sense from sellers that valuations are about as full as one could expect. Yahoo Finance executive editor Brian Sozzi sits down on the Opening Bid Unfiltered podcast with Apollo Global Management co-head of equity David Sambur. After being held by Liberation Day market related volatility, the environment for deal-making has picked up. 2025 was poised to become the second highest in deal activity, up 36% in value to an estimated $4.8 trillion according to Bain & Company. Megadeals greater than $5 billion represented more than 75% of incremental deal value. Meanwhile, exit activity for private equity companies accelerated meaningfully in the third quarter of last year. Private equity firms announced exits totaling $470 billion in 2025 per the latest data from EY, marking a 40% increase by value compared with the same period last year. Sambur shares his outlook for M&A and exits in 2026, the drivers of that potential activity and what he has learned from making big deals over the course of his career.Disclosure: Yahoo is a portfolio company of funds managed by affiliates of Apollo Global Management.",
        "pubDate": "2026-01-07T12:00:53Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/3e3c7800-eb1b-11f0-bede-3e8ac844ca3e",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OCFu1gh5Ymxk4YfrVpzHSQ--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/3e3c7800-eb1b-11f0-bede-3e8ac844ca3e.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WDrX.LnhZUbWBdzphvL2lg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/3e3c7800-eb1b-11f0-bede-3e8ac844ca3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/biggest-market-risk-2026-one-120053115.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/biggest-market-risk-2026-one-120053115.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "APO"
            },
            {
              "symbol": "BX"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "APO-PA"
            },
            {
              "symbol": "KKR"
            },
            {
              "symbol": "KKR-PD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:41:00+00:00",
    "headline": "JPMorgan Chase Cuts Ties With Proxy Advisors: Report",
    "summary": "The bank’s asset-management unit will ditch proxy advisors and use an internal AI tool to help with shareholder votes.",
    "url": "https://www.barrons.com/articles/jpmorgan-chase-proxy-advisors-report-8cf5cdb9?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e3d8375b-6e9e-3ac4-897f-f4575ef22dc1",
      "content": {
        "id": "e3d8375b-6e9e-3ac4-897f-f4575ef22dc1",
        "contentType": "STORY",
        "title": "JPMorgan Chase Cuts Ties With Proxy Advisors: Report",
        "description": "",
        "summary": "The bank’s asset-management unit will ditch proxy advisors and use an internal AI tool to help with shareholder votes.",
        "pubDate": "2026-01-07T12:41:00Z",
        "displayTime": "2026-01-07T12:41:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e3d8375b-6e9e-3ac4-897f-f4575ef22dc1/jpmorgan-chase-cuts-ties-with.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/6aafa69dd326c8a4a59d27657c415f84",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XRtuIOPh8stxeR8RTfegqQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/6aafa69dd326c8a4a59d27657c415f84.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9jeZIQOslZRf8yGBVybX1Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/6aafa69dd326c8a4a59d27657c415f84.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/jpmorgan-chase-proxy-advisors-report-8cf5cdb9?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:30:00+00:00",
    "headline": "Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026",
    "summary": "NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. (\"Protagonist\" or the \"Company\") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual ...",
    "url": "https://finance.yahoo.com/news/protagonist-therapeutics-participate-44th-annual-123000806.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2fb2c5ba-7e35-36f9-a621-5b153a43e23a",
      "content": {
        "id": "2fb2c5ba-7e35-36f9-a621-5b153a43e23a",
        "contentType": "STORY",
        "title": "Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026",
        "description": "",
        "summary": "NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. (\"Protagonist\" or the \"Company\") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual ...",
        "pubDate": "2026-01-07T12:30:00Z",
        "displayTime": "2026-01-07T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/protagonist-therapeutics-participate-44th-annual-123000806.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/protagonist-therapeutics-participate-44th-annual-123000806.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTGX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:30:00+00:00",
    "headline": "TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Presentation scheduled for Tuesday, January 13, 2026, at 1:30 PM PSTNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Tuesday, January 13, 2026, at 1:30 PM PST. A live webcast of this presentation will be available on the Events page, located within the Investors",
    "url": "https://finance.yahoo.com/news/tg-therapeutics-participate-44th-annual-123000484.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c49f1ae7-d819-3bc7-b5eb-8dcccea06473",
      "content": {
        "id": "c49f1ae7-d819-3bc7-b5eb-8dcccea06473",
        "contentType": "STORY",
        "title": "TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Presentation scheduled for Tuesday, January 13, 2026, at 1:30 PM PSTNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Tuesday, January 13, 2026, at 1:30 PM PST. A live webcast of this presentation will be available on the Events page, located within the Investors",
        "pubDate": "2026-01-07T12:30:00Z",
        "displayTime": "2026-01-07T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/175399f53a86279630f18ed710912a69",
          "originalWidth": 4274,
          "originalHeight": 1132,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yy_E2LLrhjyeO0HDMo2WQg--~B/aD0xMTMyO3c9NDI3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/175399f53a86279630f18ed710912a69.cf.webp",
              "width": 4274,
              "height": 1132,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7P9fUkYBVXZnv83WKIgUYQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/175399f53a86279630f18ed710912a69.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tg-therapeutics-participate-44th-annual-123000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tg-therapeutics-participate-44th-annual-123000484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TGTX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:30:00+00:00",
    "headline": "Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 5:15 p.m. PT (8:15 p.m. ET). A live webcast will be available in the Investor",
    "url": "https://finance.yahoo.com/news/dyne-therapeutics-present-44th-annual-123000938.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f5b9c8b6-f3c0-3997-87b3-842c09c16344",
      "content": {
        "id": "f5b9c8b6-f3c0-3997-87b3-842c09c16344",
        "contentType": "STORY",
        "title": "Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 5:15 p.m. PT (8:15 p.m. ET). A live webcast will be available in the Investor",
        "pubDate": "2026-01-07T12:30:00Z",
        "displayTime": "2026-01-07T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c24d5b28ef01b702599d83452a9a1c63",
          "originalWidth": 1479,
          "originalHeight": 447,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vUsL13rVSqhM9MJP0EGfAA--~B/aD00NDc7dz0xNDc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c24d5b28ef01b702599d83452a9a1c63.cf.webp",
              "width": 1479,
              "height": 447,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2rni.zPiZpFOFAwyWuekAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c24d5b28ef01b702599d83452a9a1c63.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dyne-therapeutics-present-44th-annual-123000938.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dyne-therapeutics-present-44th-annual-123000938.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DYN"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:00+00:00",
    "headline": "Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 07, 2026--Stylus Medicine, Inc. (\"Stylus\"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT.",
    "url": "https://finance.yahoo.com/news/stylus-medicine-present-44th-annual-120000855.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "aa16ec73-4655-3243-ab6a-2dc01ea6a469",
      "content": {
        "id": "aa16ec73-4655-3243-ab6a-2dc01ea6a469",
        "contentType": "STORY",
        "title": "Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CAMBRIDGE, Mass., January 07, 2026--Stylus Medicine, Inc. (\"Stylus\"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT.",
        "pubDate": "2026-01-07T12:00:00Z",
        "displayTime": "2026-01-07T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/98ad2ae061eb9d46d48acbe60637e1ce",
          "originalWidth": 4200,
          "originalHeight": 668,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BhEgAKgDR1e_Y_F8q.segw--~B/aD02Njg7dz00MjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/98ad2ae061eb9d46d48acbe60637e1ce.cf.webp",
              "width": 4200,
              "height": 668,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qRgCKydNqbtGCSXqgwI7ZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/98ad2ae061eb9d46d48acbe60637e1ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stylus-medicine-present-44th-annual-120000855.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stylus-medicine-present-44th-annual-120000855.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:00+00:00",
    "headline": "LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BALLERUP, Denmark, January 07, 2026--LEO Pharma CEO Christophe Bourdon will give a company update at the J.P. Morgan Healthcare Conference in San Francisco on January 13 at 9:00 AM PST",
    "url": "https://finance.yahoo.com/news/leo-pharma-present-44th-annual-120000454.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "afb01dab-ee7a-392c-92cf-4cd890a5e158",
      "content": {
        "id": "afb01dab-ee7a-392c-92cf-4cd890a5e158",
        "contentType": "STORY",
        "title": "LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "BALLERUP, Denmark, January 07, 2026--LEO Pharma CEO Christophe Bourdon will give a company update at the J.P. Morgan Healthcare Conference in San Francisco on January 13 at 9:00 AM PST",
        "pubDate": "2026-01-07T12:00:00Z",
        "displayTime": "2026-01-07T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3263c61402006f89ad1bf4153861c43d",
          "originalWidth": 480,
          "originalHeight": 366,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FUkQlw5FP6yVMAC8t0oMpw--~B/aD0zNjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3263c61402006f89ad1bf4153861c43d.cf.webp",
              "width": 480,
              "height": 366,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpjOnOLhc8vn1KEfqBl4xw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3263c61402006f89ad1bf4153861c43d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/leo-pharma-present-44th-annual-120000454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/leo-pharma-present-44th-annual-120000454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:00+00:00",
    "headline": "Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that Chris Varma, Ph.D., co-founder, chair, and chief executive officer of Frontier Medicines, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:30",
    "url": "https://finance.yahoo.com/news/frontier-medicines-present-44th-annual-120000012.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "de56d2f7-a491-32e8-95d4-d0c8f59c44d5",
      "content": {
        "id": "de56d2f7-a491-32e8-95d4-d0c8f59c44d5",
        "contentType": "STORY",
        "title": "Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that Chris Varma, Ph.D., co-founder, chair, and chief executive officer of Frontier Medicines, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:30",
        "pubDate": "2026-01-07T12:00:00Z",
        "displayTime": "2026-01-07T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b33b3c1e2ea1483d85bc8a07566b89a4",
          "originalWidth": 596,
          "originalHeight": 404,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/deHZSepn4I50dA9ZLzmjog--~B/aD00MDQ7dz01OTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b33b3c1e2ea1483d85bc8a07566b89a4.cf.webp",
              "width": 596,
              "height": 404,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IfVnkCnt1RXhZJiXX3awFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b33b3c1e2ea1483d85bc8a07566b89a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/frontier-medicines-present-44th-annual-120000012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/frontier-medicines-present-44th-annual-120000012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:00+00:00",
    "headline": "JPMorgan Cuts All Ties With Proxy Advisers in Industry First",
    "summary": "The bank’s asset and wealth-management units will use an in-house, AI-powered platform to cast shareholder votes.",
    "url": "https://www.wsj.com/finance/banking/jpmorgan-cuts-all-ties-with-proxy-advisers-in-industry-first-78c43d5f?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "55ac12f9-c805-3282-a18d-e973787ccfae",
      "content": {
        "id": "55ac12f9-c805-3282-a18d-e973787ccfae",
        "contentType": "STORY",
        "title": "JPMorgan Cuts All Ties With Proxy Advisers in Industry First",
        "description": "",
        "summary": "The bank’s asset and wealth-management units will use an in-house, AI-powered platform to cast shareholder votes.",
        "pubDate": "2026-01-07T12:00:00Z",
        "displayTime": "2026-01-07T12:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/55ac12f9-c805-3282-a18d-e973787ccfae/jpmorgan-cuts-all-ties-with.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/859cafe81f2875daabb29b378ade235a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oU3UuJFGAXxGdo9KvS5Lcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/859cafe81f2875daabb29b378ade235a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4RTS8VxzAo.hvWutKct78w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/859cafe81f2875daabb29b378ade235a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/finance/banking/jpmorgan-cuts-all-ties-with-proxy-advisers-in-industry-first-78c43d5f?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:58:47+00:00",
    "headline": "Brokerages Raise TSMC Targets After Strong Start to 2026",
    "summary": "At least six firms lift projections as JPMorgan hikes its target 24% to NT$2,100 ahead of earnings.",
    "url": "https://finance.yahoo.com/news/brokerages-raise-tsmc-targets-strong-115847096.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "4a4bae6e-5126-3c3b-9a9c-78df6f5995f7",
      "content": {
        "id": "4a4bae6e-5126-3c3b-9a9c-78df6f5995f7",
        "contentType": "STORY",
        "title": "Brokerages Raise TSMC Targets After Strong Start to 2026",
        "description": "",
        "summary": "At least six firms lift projections as JPMorgan hikes its target 24% to NT$2,100 ahead of earnings.",
        "pubDate": "2026-01-07T11:58:47Z",
        "displayTime": "2026-01-07T11:58:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/6e81bdbdd7aeb9e9aa9aa56ad2e8e47d",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PYvFdevlI1y8bN0YeLrKJA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/6e81bdbdd7aeb9e9aa9aa56ad2e8e47d.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tNDqnfAkuLuEniGSXbal.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/6e81bdbdd7aeb9e9aa9aa56ad2e8e47d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/brokerages-raise-tsmc-targets-strong-115847096.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/brokerages-raise-tsmc-targets-strong-115847096.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSM"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:30:02+00:00",
    "headline": "J.P. Morgan’s JPM Coin set for native issuance on Canton blockchain",
    "summary": "Investing.com-- Digital Asset and Kinexys by J.P. Morgan said Wednesday they intend to collaborate on bringing J.P. Morgan’s U.S. dollar deposit token, JPM Coin (ticker: JPMD), natively onto the Canton Network, marking another step toward deploying regulated digital money on blockchain infrastructure built for institutional use.",
    "url": "https://finance.yahoo.com/news/j-p-morgan-jpm-coin-133002456.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "04363afd-fe53-3b5d-a2e0-4727d6af3b2d",
      "content": {
        "id": "04363afd-fe53-3b5d-a2e0-4727d6af3b2d",
        "contentType": "STORY",
        "title": "J.P. Morgan’s JPM Coin set for native issuance on Canton blockchain",
        "description": "",
        "summary": "Investing.com-- Digital Asset and Kinexys by J.P. Morgan said Wednesday they intend to collaborate on bringing J.P. Morgan’s U.S. dollar deposit token, JPM Coin (ticker: JPMD), natively onto the Canton Network, marking another step toward deploying regulated digital money on blockchain infrastructure built for institutional use.",
        "pubDate": "2026-01-07T13:30:02Z",
        "displayTime": "2026-01-07T13:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-p-morgan-jpm-coin-133002456.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-p-morgan-jpm-coin-133002456.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "CC37263-USD"
            },
            {
              "symbol": "DX-Y.NYB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:30:00+00:00",
    "headline": "Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET. A",
    "url": "https://finance.yahoo.com/news/disc-medicine-present-44th-annual-133000787.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7cac579f-0e85-3c86-850f-e12e988596f7",
      "content": {
        "id": "7cac579f-0e85-3c86-850f-e12e988596f7",
        "contentType": "STORY",
        "title": "Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET. A",
        "pubDate": "2026-01-07T13:30:00Z",
        "displayTime": "2026-01-07T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/3cd72573afac1cc9613dbf604bf3b1cd",
          "originalWidth": 400,
          "originalHeight": 62,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZATQbkHrokiSJRRGBdEOQg--~B/aD02Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/3cd72573afac1cc9613dbf604bf3b1cd.cf.webp",
              "width": 400,
              "height": 62,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/69TrrMgpRW7piNUxZi8xVw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3cd72573afac1cc9613dbf604bf3b1cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/disc-medicine-present-44th-annual-133000787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/disc-medicine-present-44th-annual-133000787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IRON"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:03:29+00:00",
    "headline": "JPMorgan’s Kinexys Expands Digital Payments Push With Canton Network Partnership",
    "summary": "JPMorgan Chase’s blockchain unit Kinexys has announced on Tuesday it plans to bring its deposit token JPM Coin (JPMD) natively onto the Canton Network.The collaboration, unveiled in early 2026 alongside Digital Asset aims to allow the issuance, transfer and redemption of JPM Coin directly on Canton’s blockchain infrastructure. The move ...",
    "url": "https://cryptonews.com/news/jpmorgans-kinexys-expands-digital-payments-push-with-canton-network-partnership/",
    "source": "Cryptonews",
    "provider": "yfinance",
    "raw": {
      "id": "65bd1803-7c44-3e8c-b3a1-317cfca553a0",
      "content": {
        "id": "65bd1803-7c44-3e8c-b3a1-317cfca553a0",
        "contentType": "STORY",
        "title": "JPMorgan’s Kinexys Expands Digital Payments Push With Canton Network Partnership",
        "description": "",
        "summary": "JPMorgan Chase’s blockchain unit Kinexys has announced on Tuesday it plans to bring its deposit token JPM Coin (JPMD) natively onto the Canton Network.The collaboration, unveiled in early 2026 alongside Digital Asset aims to allow the issuance, transfer and redemption of JPM Coin directly on Canton’s blockchain infrastructure. The move ...",
        "pubDate": "2026-01-07T13:03:29Z",
        "displayTime": "2026-01-07T13:03:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cryptonews_us_711/3f8465ea74406e6fef8d39343258444f",
          "originalWidth": 1024,
          "originalHeight": 585,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CwomhwNMM0E4gzOT1WFW7g--~B/aD01ODU7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cryptonews_us_711/3f8465ea74406e6fef8d39343258444f.cf.webp",
              "width": 1024,
              "height": 585,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1YOic_22Jd5scJOMzhoAcA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cryptonews_us_711/3f8465ea74406e6fef8d39343258444f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Cryptonews",
          "url": "https://cryptonews.com/"
        },
        "canonicalUrl": {
          "url": "https://cryptonews.com/news/jpmorgans-kinexys-expands-digital-payments-push-with-canton-network-partnership/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-kinexys-expands-digital-payments-130329264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "DX-Y.NYB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:00:00+00:00",
    "headline": "Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 pm PT in San Francisco. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protar",
    "url": "https://finance.yahoo.com/news/protara-therapeutics-present-44th-annual-130000194.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "43000667-f1a0-3f3d-aaf1-bf3a15ea9b02",
      "content": {
        "id": "43000667-f1a0-3f3d-aaf1-bf3a15ea9b02",
        "contentType": "STORY",
        "title": "Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 pm PT in San Francisco. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protar",
        "pubDate": "2026-01-07T13:00:00Z",
        "displayTime": "2026-01-07T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b008660f8a87a3bfad7af588efe566fc",
          "originalWidth": 403,
          "originalHeight": 142,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Kovp_67KBB6.SL5vQVD5nw--~B/aD0xNDI7dz00MDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b008660f8a87a3bfad7af588efe566fc.cf.webp",
              "width": 403,
              "height": 142,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RbdS7XC32HAaTuJYdgrU4A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b008660f8a87a3bfad7af588efe566fc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/protara-therapeutics-present-44th-annual-130000194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/protara-therapeutics-present-44th-annual-130000194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TARA"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:00:00+00:00",
    "headline": "Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences",
    "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday, January 14, 2026. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of t",
    "url": "https://finance.yahoo.com/news/pacira-biosciences-present-44th-annual-130000609.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "21317696-b026-344f-8104-a2c10477ebf9",
      "content": {
        "id": "21317696-b026-344f-8104-a2c10477ebf9",
        "contentType": "STORY",
        "title": "Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences",
        "description": "",
        "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday, January 14, 2026. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of t",
        "pubDate": "2026-01-07T13:00:00Z",
        "displayTime": "2026-01-07T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b2a55687560a5971c5547ed0175e3064",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8Qjr16l5DtDKjEieP37a3g--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b2a55687560a5971c5547ed0175e3064.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RzPPDM7vqEG95mBNKogFJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b2a55687560a5971c5547ed0175e3064.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pacira-biosciences-present-44th-annual-130000609.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pacira-biosciences-present-44th-annual-130000609.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PCRX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:00:00+00:00",
    "headline": "Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco from January 12 to 15, 2026. Mike Andriole, Artios’ Chief Executive Officer, will highlight the company’s strategic priorities for its two differentiated, pote",
    "url": "https://finance.yahoo.com/news/artios-present-44th-annual-j-130000172.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "46154839-8635-39da-8ae7-3d4ed8468c29",
      "content": {
        "id": "46154839-8635-39da-8ae7-3d4ed8468c29",
        "contentType": "STORY",
        "title": "Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco from January 12 to 15, 2026. Mike Andriole, Artios’ Chief Executive Officer, will highlight the company’s strategic priorities for its two differentiated, pote",
        "pubDate": "2026-01-07T13:00:00Z",
        "displayTime": "2026-01-07T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/62a6cfc19c36e2fde57fdb1d47ffb266",
          "originalWidth": 860,
          "originalHeight": 568,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xTM36apBzzfu8TaLofyGg--~B/aD01Njg7dz04NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/62a6cfc19c36e2fde57fdb1d47ffb266.cf.webp",
              "width": 860,
              "height": 568,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3T2Lrzc4SHqA_oJEsXuGqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/62a6cfc19c36e2fde57fdb1d47ffb266.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/artios-present-44th-annual-j-130000172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/artios-present-44th-annual-j-130000172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:00:00+00:00",
    "headline": "Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finance.yahoo.com/news/novavax-participate-44th-annual-j-130000980.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "ff07152a-c893-385d-81f4-ea1211555f1a",
      "content": {
        "id": "ff07152a-c893-385d-81f4-ea1211555f1a",
        "contentType": "STORY",
        "title": "Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
        "pubDate": "2026-01-07T13:00:00Z",
        "displayTime": "2026-01-07T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0",
          "originalWidth": 400,
          "originalHeight": 176,
          "caption": "Novavax Logo (PRNewsfoto/Novavax)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lGAm3yWPXe2PzUrTUxfKZw--~B/aD0xNzY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 400,
              "height": 176,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1beS42kfkrJ3Bw2q.H.8UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1c42c28c8563f8f4990614a5b57621a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-participate-44th-annual-j-130000980.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-participate-44th-annual-j-130000980.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:59:00+00:00",
    "headline": "Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
    "summary": "GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent’s session may be accessed here and will be live for up to 30 days. The Company’s slides will be made available at the time of the presentation on the Investors section of",
    "url": "https://finance.yahoo.com/news/emergent-biosolutions-present-44th-annual-125900423.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "5547f392-8c55-3ffb-9344-b630a35ab5a0",
      "content": {
        "id": "5547f392-8c55-3ffb-9344-b630a35ab5a0",
        "contentType": "STORY",
        "title": "Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
        "description": "",
        "summary": "GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent’s session may be accessed here and will be live for up to 30 days. The Company’s slides will be made available at the time of the presentation on the Investors section of",
        "pubDate": "2026-01-07T12:59:00Z",
        "displayTime": "2026-01-07T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/dab90ee69c303ecf4430942e3bb9daca",
          "originalWidth": 566,
          "originalHeight": 67,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6HpoNq57dC8BAZ5W0pgX5Q--~B/aD02Nzt3PTU2NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/dab90ee69c303ecf4430942e3bb9daca.cf.webp",
              "width": 566,
              "height": 67,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5p4w1vx6ttymw6YHUBfdrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/dab90ee69c303ecf4430942e3bb9daca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/emergent-biosolutions-present-44th-annual-125900423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/emergent-biosolutions-present-44th-annual-125900423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EBS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:05:00+00:00",
    "headline": "BAC Shares Outpace the S&P 500 in 2025: Will Momentum Hold in 2026?",
    "summary": "BAC jumps 24.1% in 2025, beating the S&P 500 again. Will loan growth, branch expansion and a strong balance sheet keep the rally alive in 2026? Let's decipher.",
    "url": "https://finance.yahoo.com/news/bac-shares-outpace-p-500-120500886.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9db22347-3dd6-3318-af4c-d32f93c956c1",
      "content": {
        "id": "9db22347-3dd6-3318-af4c-d32f93c956c1",
        "contentType": "STORY",
        "title": "BAC Shares Outpace the S&P 500 in 2025: Will Momentum Hold in 2026?",
        "description": "",
        "summary": "BAC jumps 24.1% in 2025, beating the S&P 500 again. Will loan growth, branch expansion and a strong balance sheet keep the rally alive in 2026? Let's decipher.",
        "pubDate": "2026-01-07T12:05:00Z",
        "displayTime": "2026-01-07T12:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9a275657dd2346f560150543dcdc7d25",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OCBD8m.0juIIM3YBlEdADQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9a275657dd2346f560150543dcdc7d25.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oy9wmmQAvwBEMiGPz4y0vQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9a275657dd2346f560150543dcdc7d25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bac-shares-outpace-p-500-120500886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bac-shares-outpace-p-500-120500886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T10:00:00+00:00",
    "headline": "Business leaders are growing more optimistic, JPMorgan survey finds",
    "summary": "Almost two in five leaders at midsize businesses expressed optimism—especially about their own company’s future performance.",
    "url": "https://finance.yahoo.com/news/business-leaders-growing-more-optimistic-100000034.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "72503afa-a088-3bcc-95ac-1b3076f12ec4",
      "content": {
        "id": "72503afa-a088-3bcc-95ac-1b3076f12ec4",
        "contentType": "STORY",
        "title": "Business leaders are growing more optimistic, JPMorgan survey finds",
        "description": "",
        "summary": "Almost two in five leaders at midsize businesses expressed optimism—especially about their own company’s future performance.",
        "pubDate": "2026-01-07T10:00:00Z",
        "displayTime": "2026-01-07T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/ec4873468cbdb975d4431392456011eb",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "Melissa Smith is the co-head of commercial banking at JPMorgan.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CojEXfVEapMTspsx_dxiZw--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/ec4873468cbdb975d4431392456011eb.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VWosqwYEosl_nh8tSbDuBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/ec4873468cbdb975d4431392456011eb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/business-leaders-growing-more-optimistic-100000034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/business-leaders-growing-more-optimistic-100000034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]